|
Volumn 47, Issue 1, 2008, Pages 129-130
|
Tamoxifen: To use or not to use
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1,1,2 TRIPHENYLETHYLENE DERIVATIVE;
ANASTROZOLE;
AROMATASE INHIBITOR;
EXEMESTANE;
LETROZOLE;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
TRIAZOLE;
BREAST CANCER;
CANCER RECURRENCE;
CANCER RISK;
CANCER SCREENING;
CANCER THERAPY;
CATARACT;
CHEMOPROPHYLAXIS;
CHEMOTHERAPY;
COST EFFECTIVENESS ANALYSIS;
DEEP VEIN THROMBOSIS;
DISEASE FREE SURVIVAL;
DRUG EFFICACY;
DRUG SAFETY;
DRUG USE;
ENDOMETRIUM CANCER;
ENDOMETRIUM POLYP;
HUMAN;
IN SITU BREAST CANCER;
LETTER;
LUNG EMBOLISM;
MORTALITY;
OVARY STIMULATION;
POSTMENOPAUSE;
SIDE EFFECT;
STROKE;
SURVIVAL;
TAIWAN;
UTERUS CARCINOMA;
|
EID: 42949133477
PISSN: 10284559
EISSN: None
Source Type: Journal
DOI: 10.1016/s1028-4559(19)30087-7 Document Type: Letter |
Times cited : (1)
|
References (9)
|